| 
             
			
			 Knowing that so-called lower extremity revascularization may not 
			improve mobility allows doctors, patients and families to have more 
			realistic discussions about outcomes of the operation, said Dr. 
			Emily Finlayson, the study’s senior author from the Philip R. Lee 
			Institute for Health Policy Studies at the University of California, 
			San Francisco. 
			 
			“I think the importance of the study is that people can be sanguine 
			of the benefits of this operation in this population,” said 
			Finlayson. 
			 
			The nearly 11,000 nursing home residents in the study had a problem 
			called peripheral artery disease, which results when arteries in the 
			legs are clogged and blood flow is reduced. Pain, trouble walking, 
			poor wound healing, and even gangrene can result. 
			 
			To treat the condition, the residents underwent lower extremity 
			revascularization between 2005 and 2009, at an average age of 82. 
			Surgeons replaced or reopened their leg arteries with a small 
			balloon to improve blood flow. 
			
			  
			 
			 
			Before surgery, three quarters of the residents could not walk, and 
			40 percent had experienced a decline in overall function, the 
			authors reported in JAMA Internal Medicine. 
			 
			A year after surgery, more than half the people had died. Rates of 
			death or immobility were 63 percent among patients who were able to 
			walk before the operation, and 89 percent among those who couldn’t 
			walk before surgery. 
			 
			Also at one year, a third had a steady decline in function. 
			 
			Being 80 years old or older, having cognitive impairment, congestive 
			heart failure, kidney failure, needing emergency surgery, not being 
			able to walk before surgery or declining activities of daily living 
			were each tied to an increased risk of dying or not being able to 
			walk after lower extremity revascularization, the researchers write. 
			 
			By traditional measures, such as the ability to walk, the surgeries 
			were largely unsuccessful, said Finlayson. But she said the results 
			should be interpreted with caution. 
			“You have to back up and think of the other potential goals of the 
			operation,” she said. 
			
            [to top of second column]  | 
            
             
  
				
			For example, the goal of the operation may be to relieve severe pain 
			in a patient who has a limited life expectancy. 
			As an alternative, some people may do better with skilled wound 
			care, Finlayson said. Or in some cases an amputation may be a better 
			choice. 
			 
			“These are all things that should be on the table when you’re 
			discussing options to treat this condition in this population,” she 
			said. 
			 
			In an editorial, Dr. William Hall of the University of Rochester 
			School of Medicine in New York noted that many of the nursing home 
			residents in the study’s dataset could not walk before the surgery. 
			 
			He wrote that “most of the procedures were probably performed for 
			relief of symptoms secondary to ischemic leg pain, non-healing 
			wounds or worsening gangrene.” 
			 
			In those cases, the procedure can be viewed as a way to relieve pain 
			or discomfort – not a way to extend life or improve the ability to 
			walk. 
			 
			Finlayson said the information in the new study can be used to help 
			patient make decisions and receive care that’s in line with their 
			goals. 
			 
			SOURCE: http://bit.ly/1Gi7iWO 
			and http://bit.ly/1Gi7mG8 JAMA 
			Internal Medicine, online April 6, 2015. 
			[© 2015 Thomson Reuters. All rights 
				reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			
			   |